Chronic hyperglycaemia, the main characteristic of badly managed DM, is associated with a wide range of acute and chronic complications that can affect all the body's organs and systems, including the gingival and periodontal tissues.
Not exact matches
Chronic treatment with a glucokinase activator delays the onset of
hyperglycaemia and preserves beta cell mass in the Zucker diabetic fatty rat.
There is evidence that hyperinsulinaemia,
hyperglycaemia and
chronic inflammation may affect the neoplastic process through various pathways, including the insulin / IGF -1 pathway, and most cancer cells express insulin and IGF - 1 receptors.